<DOC>
	<DOCNO>NCT00091351</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Giving radiation therapy surgery may shrink tumor remove . It yet know whether surgery effective without radiation therapy . PURPOSE : This randomized phase III trial study surgery alone see well work compare radiation therapy together surgery treat patient primary soft tissue sarcoma retroperitoneum pelvis .</brief_summary>
	<brief_title>Surgery With Without Radiation Therapy Treating Patients With Primary Soft Tissue Sarcoma Retroperitoneum Pelvis</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare progression-free survival patient primary soft tissue sarcoma retroperitoneum pelvis treat surgery v without preoperative radiotherapy . Secondary - Compare toxicity complication associate regimens patient . - Compare rate microscopically complete surgical resection patient treat regimen . - Compare overall survival rate patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord tumor grade ( low [ G1 ] v intermediate [ G2 ] vs high [ G3/4 ] ) , tumor size ( &lt; 15 cm v ≥ 15 cm ) , tumor histology ( liposarcoma v non-liposarcoma ) . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo surgery . - Arm II : Patients undergo preoperative radiotherapy daily , 5 day week , 5.5 week . Within 28-63 day completion radiotherapy , patient undergo surgery . In arm , treatment continue absence disease progression unacceptable toxicity . Patients follow 28 day , 4 month , every 6 month 5 year , annually 5 year . PROJECTED ACCRUAL : A total 370 patient ( 185 per treatment arm ) accrue study within 4.5 year .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary soft tissue sarcoma retroperitoneum pelvis ( e.g. , iliac fossa ) The following histology eligible : Alveolar soft part sarcoma Anaplastic sarcoma Angiosarcoma Atypical lipomatous tumor ( lowgrade liposarcoma ) Clear cell sarcoma Epithelioid sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma ( subtypes ) Malignant fibrous histiocytoma Malignant peripheral nerve sheath tumor Myxofibrosarcoma Neurofibrosarcoma Spindle cell sarcoma Synovial sarcoma Unclassified sarcoma The following histology eligible : Rhabdomyosarcoma Extraosseous Ewing 's sarcoma Primitive neuroectodermal tumor Osteosarcoma Chondrosarcoma Aggressive fibromatosis ( desmoid tumor ) Gastrointestinal stromal tumor Sarcomatoid carcinoma Hemangiopericytoma Retroperitoneal sarcoma locate predominantly retroperitoneum extend across inguinal ligament abdominal wall allow provide ≥ 90 % tumor volume locate within retroperitoneal space No bowel obstruction OR history previous bowel obstruction attribute retroperitoneal tumor Primary nonvisceral retroperitoneal mass consistent sarcoma allow provided diagnosis carcinoma , melanoma , lymphoma exclude immunohistochemistry Measurable gross disease abdominopelvic CT scan ( IV oral contrast ) MRI ( IV contrast ) Patients must undergo radiotherapy consultation within past 30 day confirm feasibility preoperative externalbeam radiotherapy Patients must undergo surgical consultation within past 30 day confirm document feasibility macroscopically complete resection No prior macroscopically incomplete ( R2 ) resection ( i.e. , partial debulking subtotal tumor resection gross residual disease ) No pelvic sarcoma extend sciatic notch No clinical radiographic evidence probable metastatic disease Equivocal pulmonary liver lesion allow provide likelihood metastatic disease small No sarcoma arise bone retroperitoneal viscus ( except kidney ) No sarcoma extend across diaphragm thorax No recurrent retroperitoneal tumor No multifocal disease PATIENT CHARACTERISTICS : Age 18 Performance status ECOG 01 OR Zubrod 01 Life expectancy Not specify Hematopoietic WBC ≥ 2,500/mm^3 Platelet count ≥ 80,000/mm^3 Hepatic Bilirubin ≤ 1.5 time upper limit normal ( ULN ) AST ≤ 2.5 time ULN Albumin normal* NOTE : *Higher level allow Renal Creatinine normal BUN normal Functional kidney confirm intravenous pyelogram and/or differential renal isotope scan Other Not pregnant Negative pregnancy test Fertile patient must use effective contraception 3 month study participation No malignancy within past 5 year ( except effectively treat basal cell squamous cell skin cancer ) unless patient curatively treat AND low risk recurrence PRIOR CONCURRENT THERAPY : Chemotherapy No concurrent chemotherapy primary tumor Radiotherapy No prior abdominal pelvic irradiation No concurrent intraoperative postoperative radiotherapy primary tumor Surgery See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adult alveolar soft-part sarcoma</keyword>
	<keyword>adult angiosarcoma</keyword>
	<keyword>adult epithelioid sarcoma</keyword>
	<keyword>adult fibrosarcoma</keyword>
	<keyword>adult leiomyosarcoma</keyword>
	<keyword>adult liposarcoma</keyword>
	<keyword>adult neurofibrosarcoma</keyword>
	<keyword>adult synovial sarcoma</keyword>
	<keyword>adult malignant fibrous histiocytoma</keyword>
	<keyword>stage I adult soft tissue sarcoma</keyword>
	<keyword>stage II adult soft tissue sarcoma</keyword>
	<keyword>stage III adult soft tissue sarcoma</keyword>
</DOC>